Posterior reversible encephalopathy syndrome in a bilateral lung transplant recipient with subtherapeutic tacrolimus levels: a case report

双肺移植受者血药浓度低于治疗水平时发生后部可逆性脑病综合征:病例报告

阅读:3

Abstract

BACKGROUND: Posterior reversible encephalopathy syndrome is a rare neurological disorder typically associated with hypertension, cytotoxic agents, or supratherapeutic immunosuppressant levels. We report what appears to be the first documented case of posterior reversible encephalopathy syndrome in a bilateral lung transplant recipient occurring with subtherapeutic tacrolimus levels. CASE PRESENTATION: A 59-year-old white male with prior bilateral lung transplantation and multiple risk factors, including sepsis, corticosteroid use, and acute kidney injury, presented with sudden bilateral cortical blindness and seizures, initially concerning for stroke. Tacrolimus levels were subtherapeutic. Rapid diagnosis of posterior reversible encephalopathy syndrome was made using computed tomography stroke perfusion imaging. Intensive blood pressure control and substitution of tacrolimus with cyclosporin led to complete neurological recovery. CONCLUSION: This case highlights the multifactorial nature of posterior reversible encephalopathy syndrome and the need for vigilance even when immunosuppressant levels are subtherapeutic. Early recognition and timely management can prevent irreversible neurological injury, with important implications for transplant care and immunosuppressive therapy monitoring.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。